Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.

The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.

DERMATOLOGIC CLINICS is a leading journal in the field of dermatology, published by W B SAUNDERS CO-ELSEVIER INC. Since its inception in 1983, the journal has consistently provided a platform for the dissemination of high-quality research and clinical insights, earning its place in the prestigious Q1 quartile for dermatology in 2023. With a Scopus ranking of #34 out of 142 in its category and a commendable 76th percentile, DERMATOLOGIC CLINICS remains essential reading for clinicians, researchers, and students alike. The journal features comprehensive reviews and original articles that address the latest advancements and challenges in dermatologic diagnostics and treatments. Though it does not offer Open Access, it is widely accessible ensuring a broad readership. With a commitment to advancing the understanding of skin disorders, DERMATOLOGIC CLINICS continues to uphold its legacy of excellence in dermatological scholarship.

CONTACT DERMATITIS, published by WILEY, is a leading international journal focused on the vital field of dermatology, particularly examining the diagnosis, treatment, and management of contact dermatitis and related skin conditions. With origins dating back to 1975 and a planned convergence period extending to 2024, this esteemed journal serves as a crucial resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge in dermatological practices. In the latest rankings, it has achieved a commendable Q2 classification in Dermatology and Q3 classification in Immunology and Allergy for 2023, underscoring its significance within these dynamic fields. Moreover, it holds a notable ranking of #29/142 in Medicine & Dermatology and #130/233 in Medicine & Immunology and Allergy according to Scopus metrics, placing it in the top tier of scholarly publications. While the journal operates on a subscription basis, its comprehensive reviews, original articles, and insightful research findings are invaluable for pushing the boundaries of current dermatological and immunological knowledge. By fostering a deeper understanding of the complexities of skin reactions and their implications, CONTACT DERMATITIS plays a vital role in connecting research with clinical practice, making it an essential read for anyone engaged in the field.

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

The Journal of Skin Cancer, published by HINDAWI LTD, serves as a vital platform for advancing knowledge in the fields of Dermatology and Oncology. Established as an Open Access journal since 2011, it ensures wide dissemination of research findings, making significant contributions to the understanding of skin cancer pathogenesis, diagnosis, and treatment strategies. The journal holds a respectable rank within the academic community, reflected in its Q3 category placement in both Dermatology and Oncology for 2023, as well as its Scopus rankings, which place it in the 49th and 34th percentiles, respectively. Targeting an audience that includes researchers, healthcare professionals, and students, the Journal of Skin Cancer not only aims to present original research but also solicits reviews and case studies, thereby fostering a rich academic dialogue. With its headquarters located in London, England, the journal encourages global engagement and collaboration among scholars committed to improving outcomes in skin cancer.

The INTERNATIONAL JOURNAL OF DERMATOLOGY, published by WILEY, stands as a premier scholarly platform in the field of dermatology, with a notable impact factor that affirms its quality and renown. Established in 1963 and converging through to 2024, this journal is recognized as a Q1 category publication, ranking in the top 20% of journals within the dermatology field according to the Scopus ranking system, where it occupies the 28th position among 142 journals. This reflects its dedication to advancing the understanding and treatment of skin diseases, making it a vital resource for researchers, healthcare professionals, and medical students alike. Although it does not provide open access options, articles published in this journal cover a broad range of dermatological topics, ensuring that it serves as a comprehensive and authoritative source for cutting-edge research and clinical practices. With its rigorous peer-review process and commitment to high standards, the INTERNATIONAL JOURNAL OF DERMATOLOGY remains indispensable for those engaged in dermatological science and practice.

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

Frontiers in Allergy is a pioneering open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing the frontiers of research in the fields of Immunology and Infectious Diseases. Launched in 2020 and based in Lausanne, Switzerland, this journal provides a dynamic platform for researchers, professionals, and students to share innovative findings and insights related to allergic disorders and their broader immunological implications. With a respectable Q2 ranking in both Immunology and Allergy and Infectious Diseases categories, as well as being indexed in Scopus, this journal is emerging as a significant resource for the scientific community. The open-access model ensures wide dissemination of valuable knowledge, facilitating collaboration and breakthroughs in treatments and understanding of allergies and related conditions. Frontiers in Allergy invites contributions that drive forward the understanding of immune responses, allergy prevention, and management, solidifying its role as a crucial player in the sustainability and growth of health sciences.